INTERNATIONAL PATENT: NOVOCURE GMBH FILES APPLICATION FOR "CONCOMITANT TREATMENT WITH TTFIELDS AND HGM-COA REDUCTASE INHIBITORS"

GENEVA, Oct. 4 -- NOVOCURE GMBH (Neuhofstrasse 21CH-6340 Baar) filed a patent application (PCT/IB2025/053295) for "CONCOMITANT TREATMENT WITH TTFIELDS AND HGM-COA REDUCTASE INHIBITORS" on Mar 28, 2025. With publication no. WO/2025/202988, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GITIT, Lavy-Shahaf (c/o Novocure GmbHTopaz Building, 4th FloorMATAM Center, PO Box 15022, Sha'ar HaCamel31905 Haifa), VOLOSHIN-SELA, Tali (c/o Novocure GmbHTopaz Building, 4th FloorMATAM Center, PO Box 15022, Sha'ar HaCarmel31905 Haifa), AV...